[Significance of Mesenchymal Stem Cells in Gastrointestinal Disorders].

Gamba, S; Zhao, Y; Zhao, L; Wang, Y; Schwarz, B; Primo, S; Jauch, K-W; Nelson, P J; Modest, D P; Nieß, H; Bruns, C

[Significance of Mesenchymal Stem Cells in Gastrointestinal Disorders]. / Bedeutung mesenchymaler Stammzellen in der Viszeralmedizin.

Gamba, S; Zhao, Y; Zhao, L; Wang, Y; Schwarz, B; Primo, S; Jauch, K-W; Nelson, P J; Modest, D P; Nieß, H; Bruns, C.

Afiliación

Gamba S; Chirurgische Klinik und Poliklinik, Campus Großhadern, Klinikum der Universität München, Deutschland.
Zhao Y; Chirurgische Klinik und Poliklinik, Campus Großhadern, Klinikum der Universität München, Deutschland.
Zhao L; Chirurgische Klinik und Poliklinik, Campus Großhadern, Klinikum der Universität München, Deutschland.
Wang Y; Chirurgische Klinik und Poliklinik, Campus Großhadern, Klinikum der Universität München, Deutschland.
Schwarz B; Chirurgische Klinik und Poliklinik, Campus Großhadern, Klinikum der Universität München, Deutschland.
Primo S; Chirurgische Klinik und Poliklinik, Campus Großhadern, Klinikum der Universität München, Deutschland.
Jauch KW; Chirurgische Klinik und Poliklinik, Campus Großhadern, Klinikum der Universität München, Deutschland.
Nelson PJ; Medizinische Klinik und Poliklinik IV, Nephrologisches Zentrum und Arbeitsgruppe Klinische Biochemie, Campus Innenstadt, Klinikum der Universität München, Deutschland.
Modest DP; Medizinische Klinik und Poliklinik III, Campus Großhadern, Klinikum der Universität München, Deutschland.
Nieß H; Chirurgische Klinik und Poliklinik, Campus Großhadern, Klinikum der Universität München, Deutschland.
Bruns C; Chirurgische Klinik und Poliklinik, Campus Großhadern, Klinikum der Universität München, Deutschland.

Zentralbl Chir ; 140(3): 294-303, 2015 Jun.

Article en De | MEDLINE | ID: mdl-23836276

RESUMEN

In this review we summarise the recent developments regarding the experimental and clinical use of mesenchymal stem cells (MSCs), focusing mainly on the treatment of gastrointestinal disorders. Next to their relevance in the field of regenerative medicine and immunology, this population of cells has also raised great expectations for possible applications in cancer therapy. While clinical trials were able to demonstrate the efficacy of MSCs in cases of inflammatory bowel disease and degenerative conditions of the liver, controversial results have been presented regarding their antineoplastic potential in gastrointestinal tumours. MSCs can differentiate into a large variety of specialised cells. They are capable of regulating both wound healing and immune responses through paracrine and endocrine signalling. Moreover, MSCs can be transfected with a great number of different therapeutic genes - considering their ability to selectively migrate towards neoplastic tissues, this feature allows for targeted therapy of solid tumours. Transfected genes can be designed so that they are expressed exclusively in the vicinity of the tumour, eventually triggering apoptosis in cancer cells. In this review, we demonstrate the natural distribution of exogenously applied MSCs in the host. Furthermore, we mention various methods of tracking MSCs in vivo and different parameters of administration that tend to influence therapeutic outcome (e.g., origin of MSCs, mode of application, or the potency of transfected genes). Finally, this review points out the hazards of MSC therapy, emphasising the risks related to their widespread clinical use.

Asunto(s)

Enfermedades Gastrointestinales/terapia; Trasplante de Células Madre Mesenquimatosas; Humanos; Resultado del Tratamiento

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Enfermedades Gastrointestinales Límite: Humans Idioma: De Revista: Zentralbl Chir Año: 2015 Tipo del documento: Article Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google